![Ursula Ney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ursula Ney
Directeur/Membre du Conseil chez
PROTEOME SCIENCES PLC
Profil
Ursula M.
Ney is currently a Non-Executive Director at Proteome Sciences Plc since 2017, an Independent Non-Executive Director at Scancell Holdings Plc since 2019, a Member of the Governors Board at the University of Plymouth, and a Trustee and Member of the Governors Board at University of Plymouth Enterprise Ltd. Former roles include CEO, Executive Director, and Media Relations Contact at Calliditas Therapeutics Suisse SA in 2015; Chief Executive Officer at Charterhouse Therapeutics Ltd.; Director at Affibody AB; Chief Operating Officer and Executive Director at Sarossa Capital Ltd. from 2004 to 2010; Director at Celltech Americas, Inc.; Director and Development Director at Celltech Group Ltd.; Non-Executive Director at Discuva Ltd. from 2016 to 2017; and Principal at both Sandoz AG and Roche Diagnostics Ltd. Education includes an MBA from Middlesex University Business School, and doctorates from UCL Medical School and Royal Free Hospital Medical School.
Postes actifs de Ursula Ney
| Sociétés | Poste | Début |
|---|---|---|
| PROTEOME SCIENCES PLC | Directeur/Membre du Conseil | 01/08/2017 |
| SCANCELL HOLDINGS PLC | Directeur/Membre du Conseil | 23/10/2019 |
University of Plymouth
 University of Plymouth Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
University of Plymouth Enterprise Ltd.
 University of Plymouth Enterprise Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in exploitation of assets and intellectual property | Directeur/Membre du Conseil | - |
Anciens postes connus de Ursula Ney
| Sociétés | Poste | Fin |
|---|---|---|
Discuva Ltd.
 Discuva Ltd. Pharmaceuticals: MajorHealth Technology Develops antibiotics and drug-resistant pathogens | Directeur/Membre du Conseil | 01/12/2017 |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Directeur des opérations | 31/03/2010 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Corporate Officer/Principal | - |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | - |
Celltech Group Ltd.
 Celltech Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
Formation de Ursula Ney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
49
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Proteome Sciences Plc
 Proteome Sciences Plc Medical SpecialtiesHealth Technology Develops medical diagnostics used to identify specific diseases | Health Technology |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
University of Plymouth
University of Plymouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltech Americas, Inc. | |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Charterhouse Therapeutics Ltd. | |
Celltech Group Ltd.
Celltech Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Health Technology |
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Develops antibiotics and drug-resistant pathogens | Health Technology |
Middlesex University Business School
 Middlesex University Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCL Medical School
 UCL Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Free Hospital Medical School
 Royal Free Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Plymouth Enterprise Ltd.
University of Plymouth Enterprise Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in exploitation of assets and intellectual property | Commercial Services |
